Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSF1R | P07333 | 7/20 | 0.43 |
| ▸ | VCP | P55072 | 1/20 | 0.37 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | KCNH3 | Q9ULD8 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 2/20 | 0.35 |
| ▸ | BACE1 | P56817 | 1/20 | 0.35 |
| ▸ | ACP1 | P24666 | 1/20 | 0.34 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.34 |
| ▸ | DHODH | Q02127 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | DRD4 | P21917 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | AVPR1B | P47901 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31043039 | 1.00 | CSF1R (0.43) | CSF1RVCPNPY5RKDM4EALDH1A1 | |
| SCHEMBL29838033 | 0.95 | CSF1R (0.40) | CSF1RVCPNPY5RKDM4EALDH1A1 | |
| SCHEMBL25430443 | 0.91 | CSF1R (0.43) | CSF1RNPY5RKDM4EALDH1A1POLB | |
| SCHEMBL2995349 | 0.90 | VCP (0.37) | CSF1RVCPACHEBACE1ACP1 | |
| SCHEMBL1897623 | 0.88 | CSF1R (0.42) | CSF1RVCPNPY5RKDM4EDHODH | |
| SCHEMBL29936251 | 0.88 | CSF1R (0.45) | CSF1RNPY5RKDM4EALDH1A1POLB | |
| SCHEMBL29386984 | 0.88 | CSF1R (0.42) | CSF1RVCPNPY5RKDM4EDHODH | |
| SCHEMBL3419136 | 0.87 | CSF1R (0.41) | CSF1RKDM4EALDH1A1 | |
| SCHEMBL27800857 | 0.84 | CSF1R (0.42) | CSF1RNPY5RKDM4EALDH1A1POLB | |
| SCHEMBL3000153 | 0.84 | CSF1R (0.41) | CSF1RVCPNPY5RKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250213583-A1 | ANTIVIRAL PHARMACEUTICAL COMPOSITION AND USE THEREOF | MITOIMMUNE THERAPEUTICS INC. (KR) | 2025-07-03 | — | — | US | claimed |
| US-20250082646-A1 | OVARIAN ANTI-AGING PHARMACEUTICAL COMPOSITION AND USE THEREOF | MITOIMMUNE THERAPEUTICS INC. (KR) | 2025-03-13 | — | — | US | claimed |
| EP-4470541-A1 | OVARIAN ANTI-AGING PHARMACEUTICAL COMPOSITION AND USE THEREOF | MitoImmune Therapeutics Inc. (KR) | 2024-12-04 | — | — | EP | claimed |
| US-20240374646-A1 | COMPOSITION FOR INHIBITING INFLAMMATION OR AGING OF STEM CELLS, AND METHOD FOR INHIBITING INFLAMMATION OR AGING BY USING SAME | MITOIMMUNE THERAPEUTICS INC. (KR) | 2024-11-14 | — | — | US | claimed |
| US-20240269145-A1 | USE OF INDOLE COMPOUND AS INHIBITORS OF FERROPTOSIS | MITOIMMUNE THERAPEUTICS INC. (KR) | 2024-08-15 | — | — | US | claimed |
| EP-4382106-A1 | COMPOSITION FOR INHIBITING INFLAMMATION OR AGING OF STEM CELLS, AND METHOD FOR INHIBITING INFLAMMATION OR AGING BY USING SAME | MitoImmune Therapeutics Inc. (KR) | 2024-06-12 | — | — | EP | claimed |
| EP-2178870-B1 | INDOLE AND INDAZOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS | LG CHEMICAL LTD (KR) | 2018-09-19 | — | — | EP | claimed |
| US-20150038500-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING OPHTHALMIC DISORDERS | CATHOLIC UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2015-02-05 | — | — | US | claimed |
| US-8436038-B2 | Indole and indazole compounds as an inhibitor of cellular necrosis | LG LIFE SCIENCES LTD. (KR) | 2013-05-07 | — | — | US | claimed |
| US-8349885-B2 | Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect | LG LIFE SCIENCES LTD. (KR) | 2013-01-08 | — | — | US | claimed |
| US-20120270203-A1 | INDOLE AND INDAZOLE DERIVATIVES HAVING A CELL-, TISSUE- AND ORGAN-PRESERVING EFFECT | LG CHEM, LTD. (KR) | 2012-10-25 | — | — | US | claimed |
| EP-2230238-A2 | INDOLE AND INDAZOLE DERIVATIVES HAVING A CELL-, TISSUE- AND ORGAN-PRESERVING EFFECT | LG Life Sciences Ltd. (KR) | 2010-09-22 | — | — | EP | claimed |
| US-20100197673-A1 | INDOLE AND INDAZOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS | LG LIFE SCIENCES LTD (KR) | 2010-08-05 | — | — | US | claimed |
| EP-2178870-A1 | INDOLE AND INDAZOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS | LG Life Sciences Ltd. (KR) | 2010-04-28 | — | — | EP | claimed |
| WO-2009025478-A1 | INDOLE AND INDAZOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS | LG LIFE SCIENCES LTD. (KR) | 2009-02-26 | — | — | WO | claimed |
| EP-4470541-A1 | OVARIAN ANTI-AGING PHARMACEUTICAL COMPOSITION AND USE THEREOF | MitoImmune Therapeutics Inc. (KR) | 2024-12-04 | — | — | EP | disclosed |
| EP-4382106-A1 | COMPOSITION FOR INHIBITING INFLAMMATION OR AGING OF STEM CELLS, AND METHOD FOR INHIBITING INFLAMMATION OR AGING BY USING SAME | MitoImmune Therapeutics Inc. (KR) | 2024-06-12 | — | — | EP | disclosed |
| US-20100197673-A1 | INDOLE AND INDAZOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS | LG LIFE SCIENCES LTD (KR) | 2010-08-05 | — | — | US | disclosed |
| EP-2178870-A1 | INDOLE AND INDAZOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS | LG Life Sciences Ltd. (KR) | 2010-04-28 | — | — | EP | disclosed |
| WO-2009025478-A1 | INDOLE AND INDAZOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS | LG LIFE SCIENCES LTD. (KR) | 2009-02-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240374646-A1 | COMPOSITION FOR INHIBITING INFLAMMATION OR AGING OF STEM CELLS, AND METHOD FOR INHIBITING INFLAMMATION OR AGING BY USING SAME | TFAM, FIS1, AIFM1 | CSF1R 1534/4885VCP 1138/4885NPY5R 4501/4885 |
| US-20250082646-A1 | OVARIAN ANTI-AGING PHARMACEUTICAL COMPOSITION AND USE THEREOF | CYP19A1, NR5A1, CYP11A1 | CSF1R 4503/4885VCP 602/4885NPY5R 2777/4885 |
| US-20250213583-A1 | ANTIVIRAL PHARMACEUTICAL COMPOSITION AND USE THEREOF | ZC3HAV1, ZC3HAV1L, SARS1 | CSF1R 3618/4885VCP 2469/4885NPY5R 4482/4885 |
| US-20120270203-A1 | INDOLE AND INDAZOLE DERIVATIVES HAVING A CELL-, TISSUE- AND ORGAN-PRESERVING EFFECT | IDO1, IDO2, INMT | CSF1R 2444/4885VCP 4243/4885NPY5R 1549/4885 |
| US-20100197673-A1 | INDOLE AND INDAZOLE COMPOUNDS AS AN INHIBITOR OF CELLULAR NECROSIS | IDO1, IDO2, NFATC1 | CSF1R 2910/4885VCP 3548/4885NPY5R 2110/4885 |
| US-20150038500-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING OPHTHALMIC DISORDERS | AQP1, EYA3, SF1 | CSF1R 3822/4885VCP 2813/4885NPY5R 3163/4885 |
| US-20240269145-A1 | USE OF INDOLE COMPOUND AS INHIBITORS OF FERROPTOSIS | AIFM2, FECH, SLC40A1 | CSF1R 1524/4885VCP 3822/4885NPY5R 2213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.